http://orcid.org/0000-0003-2794-0062
References
- Luther B, Mamopoulos A, Lehmann C, Klar E. The ongoing challenge of acute mesenteric ischemia. Visc Med. 2018;34(3):217–223.
- Bala M, Kashuk J, Moore EE, et al. Acute mesenteric ischemia: guidelines of the World Society of Emergency Surgery. World J Emerg Surg. 2017.
- Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, Mcmillan DC, Clarke SJ. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol. 2013;88(1):218–230.
- Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010;140(6):883–899.
- Aliustaoglu M, Bilici A, Ustaalioglu BB, et al. The effect of peripheral blood values on prognosis of patients with locally advanced gastric cancer before treatment. Med Oncol. 2010;27(4):1060–1065.
- Pan QX, Su ZJ, Zhang JH, Wang CR, Ke SY. A comparison of the prognostic value of preoperative inflammation-based scores and TNM stage in patients with gastric cancer. Onco Targets Therapy. 2015;8:1375–1385.
- Karadeniz E, Bayramoğlu A, Atamanalp SS. Sensitivity and specificity of the platelet-lymphocyte ratio and neutrophil-lymphocyte ratio in the diagnosis of acute mesenteric ischemia in patients having undergone surgery for mesenteric ischemia; a retrospective case-controlled study. J Invest Surg. 2019;33(8):774–781.
- Toptas M, Akkoc İ, Savas Y, Uzman S, Toptas Y, Can MM. Novel hematologic inflammatory parameters to predict acute mesenteric ischemia. Blood Coagul Fibrinolysis. 2016;27(2):127–130.
- Tanrıkulu Y, Şen Tanrıkulu C, Sabuncuoğlu MZ, Temiz A, Köktürk F, Yalçın B. Diagnostic utility of the neutrophil-lymphocyte ratio in patients with acute mesenteric ischemia: A retrospective cohort study. Ulus Travma Acil Cerrahi Derg. 2016;22(4):344–349.